A drug that lowers a blood protein, causing ocular impairment and blindness in many users, was approved despite questionable data and significant healthcare costs.

“there's a drug which i always forget the name it's a drug that lowers the rate of a blood protein but almost everybody who takes the drug suffers ocular impairment and some people suffer severe ocular impairment so there's a lot of blindness going on or pre-blindness like conditions but i don't know if people live longer i don't know if they live better i know they have to see the ophthalmologist a lot that adds more health care costs costs a ton why is this approved i mean why can't we wait for a little bit better data”